INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-2.76 Cr | ₹3.31 Cr | ₹-6.54 Cr | ₹8.05 Cr | ₹-14 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDOCO REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-2.76 Cr |
| Mar2024 | ₹3.31 Cr |
| Mar2023 | ₹-6.54 Cr |
| Mar2022 | ₹8.05 Cr |
| Mar2021 | ₹-14 Cr |
How is Net Cash Inflow / Outflow of INDOCO REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.76 Cr | Negative | |
| Mar2024 | ₹3.31 Cr | Positive | |
| Mar2023 | ₹-6.54 Cr | Negative | |
| Mar2022 | ₹8.05 Cr | Positive | |
| Mar2021 | ₹-14 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,014.0 Cr | -1.9% | -11.3% | -24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,394.0 Cr | -2.3% | -3.3% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,312.0 Cr | 0.3% | 16.3% | 44.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,678.0 Cr | 2.8% | -0.5% | 37.1% | Stock Analytics | |
| CIPLA | ₹114,392.0 Cr | -3.1% | -1.2% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,740.5 Cr | -2.9% | -3% | -3.3% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.9% |
-11.3% |
-24.4% |
| SENSEX | -1.4% |
-1% |
-4.6% |
You may also like the below Video Courses